Showing results (131-140 of 516) with videos related to

Sort By:
Pageof 52
Pulmonary Pharmacology & Therapeutics|January 10, 2017
Acute cardiovascular safety of two formulations of beclometasone dipropionate/formoterol fumarate in COPD patients: A single-dose, randomised, placebo-controlled crossover studyDave Singh, Giorgia Ciurlia, Annalisa Piccinno, et al.
Lancet (London, England)|May 7, 2015
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised managementPrescott G Woodruff, Alvar Agusti, Nicolas Roche, et al.
Pulmonary Pharmacology & Therapeutics|July 31, 2012
Relief of methacholine-induced bronchospasm with extrafine beclomethasone dipropionate/formoterol in comparison with salbutamol in asthmaDave Singh, Massimo Corradi, Eddi Bindi, et al.
Biotechnology and Applied Biochemistry|March 30, 2022
Pharmacological evaluation of the effects of enzymatically liberated fish oil on eosinophilic inflammation in animal modelsCrawford Currie, Bomi Framroze, Dave Singh, et al.
Respiratory Medicine|January 25, 2006
A comparison of exhaled nitric oxide measurements performed using three different analysersZoë Borrill, David Clough, Nick Truman, et al.
Pharmacology Research & Perspectives|February 7, 2025
Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Inhaled Voriconazole in Healthy Volunteers and Subjects With Stable AsthmaGiovanni Caponetti, Federica Sala, Antonio Cervetti, et al.
Clinical and Translational Science|July 28, 2021
Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19Nathan D Pfeifer, Arthur Lo, David L Bourdet, et al.
Plos One|August 27, 2013
Down regulation of T cell receptor expression in COPD pulmonary CD8 cellsSeamus Grundy, Jonathan Plumb, Simon Lea, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 9, 2021
The Perception of Physicians on Gender-Specific Differences in the Diagnosis of COPD: Results from a Questionnaire-Based SurveyChantal Raherison-Semjen, Karen Mezzi, Konstantinos Kostikas, et al.
International Journal of General Medicine|December 21, 2013
Inhibition of the early asthmatic response to inhaled allergen by the 5-lipoxygenase activating protein inhibitor GSK2190915: a dose-response studyDave Singh, Malcolm Boyce, Virginia Norris, et al.
Pageof 52